Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabidiol and stroke:

Search results

Items: 1 to 20 of 28

1.

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.

Patra PH, Barker-Haliski M, White HS, Whalley BJ, Glyn S, Sandhu H, Jones N, Bazelot M, Williams CM, McNeish AJ.

Epilepsia. 2019 Feb;60(2):303-314. doi: 10.1111/epi.14629. Epub 2018 Dec 26.

PMID:
30588604
2.

Epilepsy and Cannabis: A Literature Review.

Zaheer S, Kumar D, Khan MT, Giyanwani PR, Kiran F.

Cureus. 2018 Sep 10;10(9):e3278. doi: 10.7759/cureus.3278. Review.

3.

Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development.

Bialer M, Johannessen SI, Koepp MJ, Levy RH, Perucca E, Tomson T, White HS.

Epilepsia. 2018 Oct;59(10):1842-1866. doi: 10.1111/epi.14555. Erratum in: Epilepsia. 2019 Jan;60(1):187.

PMID:
30368788
4.

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.

Rodríguez-Muñoz M, Onetti Y, Cortés-Montero E, Garzón J, Sánchez-Blázquez P.

Mol Brain. 2018 Sep 17;11(1):51. doi: 10.1186/s13041-018-0395-2.

5.

Cardiovascular Complications of Marijuana and Related Substances: A Review.

Singh A, Saluja S, Kumar A, Agrawal S, Thind M, Nanda S, Shirani J.

Cardiol Ther. 2018 Jun;7(1):45-59. doi: 10.1007/s40119-017-0102-x. Epub 2017 Dec 7. Review.

6.

Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention.

Scharf EL.

Cannabis Cannabinoid Res. 2017 Oct 1;2(1):259-264. doi: 10.1089/can.2017.0033. eCollection 2017. Review.

7.

A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.

Marinelli L, Balestrino M, Mori L, Puce L, Rosa GM, Giorello L, Currà A, Fattapposta F, Serrati C, Gandolfo C, Abbruzzese G, Trompetto C.

BMJ Open. 2017 Sep 7;7(9):e016843. doi: 10.1136/bmjopen-2017-016843.

8.

Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia.

Khaksar S, Bigdeli MR.

Brain Inj. 2017;31(13-14):1932-1943. doi: 10.1080/02699052.2017.1358397. Epub 2017 Sep 5.

PMID:
28872345
9.

A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.

Jadoon KA, Tan GD, O'Sullivan SE.

JCI Insight. 2017 Jun 15;2(12). pii: 93760. doi: 10.1172/jci.insight.93760. [Epub ahead of print]

10.

Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model.

Khaksar S, Bigdeli MR.

Basic Clin Neurosci. 2017 Mar-Apr;8(2):139-146. doi: 10.18869/nirp.bcn.8.2.139.

11.

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).

Klein BD, Jacobson CA, Metcalf CS, Smith MD, Wilcox KS, Hampson AJ, Kehne JH.

Neurochem Res. 2017 Jul;42(7):1939-1948. doi: 10.1007/s11064-017-2287-8. Epub 2017 May 6.

PMID:
28478594
12.

Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome.

Kaplan EH, Offermann EA, Sievers JW, Comi AM.

Pediatr Neurol. 2017 Jun;71:18-23.e2. doi: 10.1016/j.pediatrneurol.2017.02.009. Epub 2017 Feb 22.

PMID:
28454984
13.

A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol.

Sultan SR, Millar SA, England TJ, O'Sullivan SE.

Front Pharmacol. 2017 Feb 24;8:81. doi: 10.3389/fphar.2017.00081. eCollection 2017.

14.

Strokes are possible complications of cannabinoids use.

Wolff V, Jouanjus E.

Epilepsy Behav. 2017 May;70(Pt B):355-363. doi: 10.1016/j.yebeh.2017.01.031. Epub 2017 Feb 23. Review.

PMID:
28237318
15.

Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.

Ceprián M, Jiménez-Sánchez L, Vargas C, Barata L, Hind W, Martínez-Orgado J.

Neuropharmacology. 2017 Apr;116:151-159. doi: 10.1016/j.neuropharm.2016.12.017. Epub 2016 Dec 21.

PMID:
28012949
16.

Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia.

Khaksar S, Bigdeli MR.

Eur J Pharmacol. 2017 Jan 5;794:270-279. doi: 10.1016/j.ejphar.2016.11.011. Epub 2016 Nov 14.

PMID:
27856160
17.

Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.

Hind WH, England TJ, O'Sullivan SE.

Br J Pharmacol. 2016 Mar;173(5):815-25. doi: 10.1111/bph.13368. Epub 2016 Feb 3.

18.

Cannabinoids in experimental stroke: a systematic review and meta-analysis.

England TJ, Hind WH, Rasid NA, O'Sullivan SE.

J Cereb Blood Flow Metab. 2015 Mar;35(3):348-58. doi: 10.1038/jcbfm.2014.218. Epub 2014 Dec 10. Review.

19.

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.

Pertwee RG.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3353-63. doi: 10.1098/rstb.2011.0381. Review.

20.

Is the cardiovascular system a therapeutic target for cannabidiol?

Stanley CP, Hind WH, O'Sullivan SE.

Br J Clin Pharmacol. 2013 Feb;75(2):313-22. doi: 10.1111/j.1365-2125.2012.04351.x. Review.

Supplemental Content

Loading ...
Support Center